Katsuya Suzuki

Katsuya Suzuki


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
KUKentaro Umeda
Kentaro Umeda
DSDaichi Shindo
Daichi Shindo
SSShinji Somekawa
Shinji Somekawa
SNShinobu Nishitani
Shinobu Nishitani
WSWataru Sato
Wataru Sato
KSKatsuya Suzuki
Katsuya Suzuki
Background: The importance of maintaining good mental health with overall well-being has recently drawn attention from various spheres of academics and the working population. Amino acid intake has been reported to reduce depression symptoms and other mental health problems. However, the effectiveness of amino acid intake (i.e., single or combined) remains unknown. In this study, we assessed a combination of five amino acids (serine, alanine, glutamate, aspartate, and tyrosine; SAGAT) reported to regulate mental health. Methods: A randomized, double-blind, placebo-controlled exploratory trial was conducted. Participants, aged between 20 and 65 years with fatigue sensation, were randomized to receive either SAGAT or the placebo and ingested them for four weeks. A transient mental work was loaded at day 0 and after four weeks of intervention. As the primary outcomes, the fatigue sensation was assessed. The mood status, cognitive function, work efficiency, and blood marker were also measured as secondary outcomes. Results: The number of participants analyzed for the efficacy evaluation were 20 in SAGAT and 22 in the placebo. There were no significant differences in the primary outcomes. However, as the secondary outcomes, the SAGAT group showed a significant improvement in motivation and cognitive function in the recovery period after mental work loaded in a four-week intervention compared to the placebo. Conclusion: The current findings suggest that SAGAT contributes to maintaining proper motivation and cognitive function. Clinical Trial Registration: University Hospital Medical Information Network Clinical Trial Registry (ID: UMIN 000041221).

31 July 2024 in European Journal of Nutrition
Verified
Journal Article
Open access
PDF file
KSKatsuya Suzuki
Katsuya Suzuki
YOYoriko Okamatsu
Yoriko Okamatsu
RURyo Uchida
Ryo Uchida
ISIkuko Sasahara
Ikuko Sasahara
MTMasamichi Takeshita
Masamichi Takeshita
HMHitoshi Murakami
Hitoshi Murakami
Purpose: The importance of maintaining good mental health with overall well-being has recently drawn attention from various fields. Functional peptides found from various protein sources reportedly reduce mental health problems. We found a new decapeptide (AJI-801) from whey proteins, which can possibly improve mood status and increase blood acetyl-L-carnitine (ALC) and fibroblast growth factor 21 (FGF21) levels. In this study, we assessed the effects of a single intake of whey protein hydrolysate containing a high amount of AJI-801 (WPH) on blood variables and mood status. Methods: A randomized, double-blind, placebo-controlled cross-over trial of two doses of WPH (100 and 500 mg) was conducted. Participants, aged between 20 and 59 years with fatigue were allocated to two groups based on the WPH doses received, and set first test food in each study. The blood ALC and FGF21 levels at baseline and after 60, 120, and 180 min of test food intake were analyzed and the responses to the questionnaire items for mood status were obtained at baseline and after 60 and 180 min of test food intake. Results: There were no significant differences in the blood ALC and FGF21 levels between the two groups. As mood status, intake of 500-mg WPH (including 2.5-mg AJI-801) showed significant improvement in Depression/Dejection of the Profile of Mood States Questionnaire second edition and visual analog scale score for depression, as compared to the placebo. Conclusions: Intake of AJI-801 500-mg WPH (including 2.5-mg AJI-801) contributes to the improvement of feeling down in healthy persons with fatigue. Trial registration: University Hospital Medical Information Network Clinical Trial Registry (UMIN 000046829).

22 September 2025 in European Journal of Nutrition
Verified
Journal Article
Open access
PDF file
KSKatsuya Suzuki
Katsuya Suzuki
YOYoriko Okamatsu
Yoriko Okamatsu
RURyo Uchida
Ryo Uchida
ISIkuko Sasahara
Ikuko Sasahara
MTMasamichi Takeshita
Masamichi Takeshita
HMHitoshi Murakami
Hitoshi Murakami